Dr. Petracek to Present on Pre-Marketing Clinical Safety - January 26-27, 2016 in London
Jan 11, 2016
PharmInvent‘s CEO Dr. Jan Petracek will be presenting and leading discussions at another DIA training course titled: "Pre-Marketing Clinical Safety".
The course is taking place January 26-27th, 2016 in London, UK and will be covering a range of topics including the following:
- DSUR (development safety update reports)
- Safety Risk Management best practices
- SUSARs reporting
- Adverse events management best practices
- EudraVigilance CT Modules
For complete details of the program, please view the DIA training course link.
Registration is still available for this event and details can be found on this page: Pre-Marketing Clinical Safety Registration.
Dr. Jan Petracek participates in regular trainings with DIA and other Pharmacovigilance related organizations worldwide. He serves as an advisor and EU-QPPV for several high profile pharmaceutical organizations and is a trusted resource for regulators within the European Union.
As one of the most well known world leaders in the industry, his lectures and trainings have been utilized by thousands of PV professionals across every continent.
If your organization is interested in inviting Dr. Petracek or his team to speak or conduct internal trainings, please fill in the online form with your request.